Funding for this research was provided by:
Fundamental Research Funds of the State Key Laboratory of Ophthalmology (N/A, N/A)
Research Accelerator Program of University of Melbourne (N/A)
CERA Foundation (N/A)
Science and Technology Program of Guangzhou, China (202002020049)
Project of Special Research on Cardiovascular Diseases (2020XXG007)
National Natural Science Foundation of China (81870663, 82171075, 82101173, 82000901)
Outstanding Young Talent Trainee Program of Guangdong Provincial People’s Hospital (KJ012019087)
Guangdong Provincial People’s Hospital Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province (KJ012019457)
Talent Introduction Fund of Guangdong Provincial People’s Hospital (Y012018145)
Research Foundation of Medical Science and Technology of Guangdong Province (B2021237)
Received: 13 February 2022
Accepted: 21 June 2022
First Online: 15 August 2022
: Northwest Multi-Centre Research Ethics Committee (11/NW/0382) gave their ethical approval for the original UK Biobank study. Informed consent was obtained from each participant. Our study was conducted in accordance to the Declarations of Helsinki. Our access to data from the UK Biobank cohort was approved by the UKB Ethics Advisory Committee (application ID: 62443).
: Not applicable.
: The authors declare that they have no competing interests.